Key result
Pre-PCI exosomal protein P60891 predicts 1-year heart failure with an AUC of 0.87.
Why the study?
Plasma exosomal proteins detected in the acute stage of ASTEMI are supposed to affect patient outcomes after PCI but their prognostic value is unclear.
Do plasma exosomal proteins predict the 1-year prognosis of patients with acute ST-segment elevation myocardial infarction after emergency PCI?
Observational (n=20)
No
Do plasma exosomal proteins predict the 1-year prognosis of patients with acute ST-segment elevation myocardial infarction after emergency PCI?
Specific plasma exosomal proteins measured during the acute phase of STEMI can strongly predict the 1-year risk of heart failure and coronary reintervention following primary PCI.
Answers are grounded in this paper and cite their sources.
Exosomal proteomics may identify prognostic biomarkers in acute STEMI; leaves open validation before any clinical application.
Acute ST-segment elevation myocardial infarction (ASTEMI) leads to great morbidity and mortality, even after immediate reperfusion therapy by primary percutaneous coronary intervention (PCI). Plasma exosomal proteins detected in the acute stage are supposed to affect the outcomes of ASTEMI. The present study collected ASTEMI patients with ischemic time around 6 hours and underwent successful emergency PCI, used exosomal proteomics to identify the plasma exosomal proteins, and performed a 1-year follow-up on ASTEMI outcomes. We observed that plasma exosomes concentration significantly decreased in ASTEMI after PCI than before it. Receiver operating characteristic (ROC) curve analysis revealed that several plasma exosomal proteins detected were strong predictors for coronary reintervention, which were revalidated in Cox regressions; while several plasma exosomal proteins were strong predictors for heart failure, which were revalidated in logistic regressions. The protein–protein network interactions and literature review suggest that plasma exosomal proteins might correlate with ASTEMI prognosis though involving in lipid and carbohydrate metabolism, regulation of cardiac muscle contraction, inflammation, platelet activation, or ferroptosis. Our results provide potential preventive and therapeutic targets for ASTEMI outcomes after PCI.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted an observational in Acute ST-segment elevation myocardial infarction (ASTEMI) (n=20). Plasma exosomal proteins was evaluated on Heart failure (predicted by pre-PCI P60891 protein level) (AUC 0.87, 95% CI 0.70-1.00, p=0.011). Plasma exosomal protein P60891 detected before PCI was a strong predictor of heart failure, while several other proteins predicted coronary reintervention at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: